These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35471988)

  • 1. Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.
    Gordon SF; Virah Sawmy E; Duckworth E; Wolthuizen M; Clothier HJ; Chea M; Tenneti N; Blow N; Buttery JP; de Luca J; Korman TM; Barnes S; Slade C; Maggs C; Giles ML; Teh BW; Aboltins C; Langan KM; Van Diemen A; Crawford NW
    Hum Vaccin Immunother; 2022 Nov; 18(5):2052701. PubMed ID: 35471988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021.
    Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
    Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
    Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
    Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best practice implementation on reporting of coronavirus disease 2019 vaccine adverse events following immunization in Uasin Gishu County, Kenya.
    Amdany H; Koech B
    JBI Evid Implement; 2023 Jun; 21(2):146-155. PubMed ID: 36545897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018.
    Clothier HJ; Lawrie J; Lewis G; Russell M; Crawford NW; Buttery JP
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32536336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline.
    Laemmle-Ruff I; Lewis G; Clothier HJ; Dimaguila GL; Wolthuizen M; Buttery J; Crawford NW
    Front Public Health; 2022; 10():1053637. PubMed ID: 36408022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.
    Nyambayo PPM; Gold MS; Mehta UC; Clarke S; Manyevere R; Chirinda L; Zifamba EN; Nyamandi T
    Vaccine; 2023 Oct; 41(45):6700-6709. PubMed ID: 37805357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to receive a vaccine is influenced by adverse events following immunisation experienced by others.
    Christou-Ergos M; Wiley KE; Leask J
    Vaccine; 2023 Jan; 41(1):246-250. PubMed ID: 36446655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of adverse effects following immunisation degree after the administration COVID-19 vaccine of different platforms.
    Bermawi B; Donastin A; Sari NDK; Kurniasari DW; Adriansyah AA; Ferdiansyah MA; Rofananda IF; Surya PA
    Med J Malaysia; 2024 Mar; 79(2):124-127. PubMed ID: 38553914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events following immunization of COVID-19 vaccine among children aged 6-11 years.
    Puspitarani F; Sitaresmi MN; Ahmad RA
    Front Public Health; 2022; 10():999354. PubMed ID: 36388348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
    Clothier HJ; Crawford N; Russell MA; Buttery JP
    Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review.
    Bhandari B; Rayamajhi G; Lamichhane P; Shenoy AK
    Biomed Res Int; 2022; 2022():2911333. PubMed ID: 36017393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of adverse events following immunisation: Australia, 2000-2002.
    Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
    Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
    Kant A; Jansen J; van Balveren L; van Hunsel F
    Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study.
    Serhan M; Psihogios A; Kabir N; Bota AB; Mithani SS; Smith DP; Zhu DT; Greyson D; Wilson S; Fell D; Top KA; Bettinger JA; Wilson K
    Hum Vaccin Immunother; 2024 Dec; 20(1):2293550. PubMed ID: 38374618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of adverse events following immunisation in Australia annual report, 2021.
    Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
    Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.